Philip H Abbosh
Overview
Explore the profile of Philip H Abbosh including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
246
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kulkarni G, Guzzo T, Abbosh P, Huang W, Shore N, Smith Z, et al.
Clin Genitourin Cancer
. 2025 Mar;
23(3):102313.
PMID: 40068366
Introduction: Treatment patterns for patients with bacillus Calmette-Guérin (BCG)-unresponsive high-risk non-muscle-invasive bladder cancer (NMIBC) who are ineligible for or decline radical cystectomy (RC) are inconsistently reported. We retrospectively described demographic,...
2.
Braun A, Deng M, Hasler J, Bukavina L, Handorf E, Abbosh P
BMC Med
. 2025 Feb;
23(1):117.
PMID: 40001066
Background: Antibiotic therapy (ABT)-induced dysbiosis may affect the efficacy of immune checkpoint inhibitors (ICI) therapy. We investigated the association between ABT and real-world overall survival (rwOS) and progression-free survival (rwPFS)...
3.
Geynisman D, Abbosh P, Ross E, Zibelman M, Ghatalia P, Anari F, et al.
J Clin Oncol
. 2024 Dec;
43(9):1113-1122.
PMID: 39680823
Purpose: Cisplatin-based neoadjuvant chemotherapy (NAC) followed by cystectomy is the standard of care for patients with muscle-invasive bladder cancer (MIBC). Mutations in DNA damage repair genes are associated with pathologic...
4.
Correa A, Kalashnikova E, Wu H, Winters R, Balcioglu M, Sudhaman S, et al.
Oncologist
. 2024 Jul;
29(10):887-893.
PMID: 39013784
Background: Despite complete resection, 20%-50% of patients with localized renal cell carcinoma (RCC) experience recurrence within 5 years. Accurate assessment of prognosis in high-risk patients would aid in improving outcomes....
5.
Satyal U, Valentine H, Liu D, Slifker M, Lallas C, Trabulsi E, et al.
JCO Precis Oncol
. 2024 Jun;
8:e2300362.
PMID: 38865671
Purpose: There is significant interest in identifying complete responders to neoadjuvant chemotherapy (NAC) before radical cystectomy (RC) to potentially avoid removal of a pathologically benign bladder. However, clinical restaging after...
6.
Bukavina L, Ginwala R, Eltoukhi M, Sindhani M, Prunty M, Geynisman D, et al.
Cancer Res Commun
. 2024 May;
4(6):1505-1516.
PMID: 38747616
Significance: Our study highlights results that link the composition of the GM to the efficacy of NAC in MIBC. We discovered that patients with higher levels of Bacteroides experienced a...
7.
Purdue M, Dutta D, Machiela M, Gorman B, Winter T, Okuhara D, et al.
Nat Genet
. 2024 Apr;
56(5):809-818.
PMID: 38671320
Here, in a multi-ancestry genome-wide association study meta-analysis of kidney cancer (29,020 cases and 835,670 controls), we identified 63 susceptibility regions (50 novel) containing 108 independent risk loci. In analyses...
8.
Bukavina L, Ginwala R, Sindhani M, Prunty M, Geynisman D, Pooja G, et al.
bioRxiv
. 2023 Feb;
PMID: 36747848
Treatment with neoadjuvant chemotherapy (NAC) in muscle invasive bladder cancer (MIBC) is associated with clinical benefit in urothelial carcinoma. While extensive research evaluating role of tumor mutational expression profiles and...
9.
Mishra K, Isali I, Sindhani M, Prunty M, Bell S, Mahran A, et al.
Eur Urol Focus
. 2022 Dec;
9(4):669-680.
PMID: 36566099
Background: While microbiome and host regulation contribute independently to many disease states, it is unclear how circumcision in pediatric population influences subsequent changes in penile microbiome. Objective: Our study aims...
10.
Bukavina L, Prunty M, Isali I, Calaway A, Ginwala R, Sindhani M, et al.
Eur Urol Open Sci
. 2022 Nov;
43:5-13.
PMID: 36353067
Background: Until recently, the properties of microbiome and mycobiome in humans and its relevance to disease have largely been unexplored. While the interest of microbiome and malignancy over the past...